COVID19 Update: For your safety, you will be asked to use a mask, if you do not have one, a mask will be provided. If a person presents with a temperature, you will be asked to return home and further instructions will be given by your health care team. For our patients protection, no visitors under 18 will be allowed in the offices, there is a limit one (1) visitor per patient if necessary. No visitors are allowed in the chemo infusion room. Telemedicine are available for routine office visits. More Information-PLEASE CLICK HERE

Co Author Alex Spira, MD - Lung Cancer Study Treatment Option for ALK Positive Lung Cancer Patients

Virginia Cancer Specialists Practice Blog

September 25, 2018
Virginia Cancer Specialists » VCS Practice News » Physicians » VCS Practice News » Alex Spira MD PhD FACP » Co Author Alex Spira, MD – Lung Cancer Study Treatment Option for ALK Positive Lung Cancer Patients

Co Author Alex Spira, M.D., PhD, F.A.C.P. @AlexSpiraMDPhD – Congratulations tor our Virginia Cancer Specialists Research Team on contributing to the lung cancer literature, and most importantly another treatment option for our patients with ALK positive lung cancer! Reminds us why we work so hard to give our patients access to research. #CancerResearch #CancerTrials

See the Study Here:

Brigatinib versus Crizotinib in ALK-Positive Non–Small-Cell Lung Cancer | NEJM